Name: Net Profit Margin

Definition: Net profit margin shows how much profit remains after paying all costs — including operating expenses, interest, and taxes — for every dollar of sales. A higher margin means the business is efficient and keeps more of its sales as bottom-line profit. Falling margins may signal rising costs or pricing pressure.

Interpretation:
• In '2021', ABSI's net profit margin was -2111.2%, measuring the overall profitability of the company. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2021' stood at -55.8%.
• In '2022', ABSI's net profit margin was -1825.4%, measuring the overall profitability of the company. The increase since '2021' reflects strengthening financial performance. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2022' stood at -19.5%. Industry average increased by 36.3% compared to previous year.
• In '2023', ABSI's net profit margin was -1933.7%, measuring the overall profitability of the company. The decline from '2022' may indicate some operational or financial challenges. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2023' stood at -81.9%. Industry average declined by 62.4% from previous year.
• In '2024', ABSI's net profit margin was -2274.1%, measuring the overall profitability of the company. The decline from '2023' may indicate some operational or financial challenges. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2024' stood at -66.9%. Industry average increased by 15.0% compared to previous year.
Overall, ABSI's net profit margin has been volatile but showed a downward trend over the past 4 years.

Formula: Net Profit Margin = Net Income / Revenue

Good Range: Ranges 5%-20% for many industries.